Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
, (1), CD000480

Vinpocetine for Acute Ischaemic Stroke

Affiliations
Review

Vinpocetine for Acute Ischaemic Stroke

D Bereczki et al. Cochrane Database Syst Rev.

Abstract

Background: Vasoactive and neuroprotective drugs such as vinpocetine are used to treat stroke in some countries.

Objectives: To assess the effect of vinpocetine in acute ischaemic stroke.

Search strategy: We searched the Cochrane Stroke Group Trials Register (last searched February 2007), MEDLINE (1966 to February 2007) and Scopus (1960 to February 2007). We also searched the Internet Stroke Center Stroke Trials Registry, Google Scholar, the science-specific search engine Scirus and Wanfang Data, the leading information provider in China. We contacted researchers in the field and four pharmaceutical companies that manufacture vinpocetine. Searches were complete to February 2007.

Selection criteria: Unconfounded randomised trials of vinpocetine compared with placebo, or any other reference treatment, in people with acute ischaemic stroke. We included trials if treatment started no later than 14 days after stroke onset.

Data collection and analysis: Two review authors independently applied the inclusion criteria. One review author extracted the data, which was then checked by the second review author. We assessed trial quality. The primary outcome measure was death or dependency.

Main results: We included two trials, involving a total of 70 participants. Data for 63 participants were reported in the two trials combined. The rate of death or dependency did not differ between the treatment and placebo groups at one and three months. The 95% confidence intervals for the outcome measures were wide and included the possibility of both significant benefit and significant harm. No adverse effects were reported.

Authors' conclusions: There is not enough evidence to evaluate the effect of vinpocetine on survival or dependency in patients with acute ischaemic stroke.

Update of

  • Vinpocetine for Acute Ischaemic Stroke
    D Bereczki et al. Cochrane Database Syst Rev (2), CD000480. PMID 10796369. - Review
    There is not enough evidence to evaluate the effect of vinpocetine on survival or dependency of patients with acute stroke.

Similar articles

  • Vinpocetine for Acute Ischaemic Stroke
    D Bereczki et al. Cochrane Database Syst Rev (2), CD000480. PMID 10796369. - Review
    There is not enough evidence to evaluate the effect of vinpocetine on survival or dependency of patients with acute stroke.
  • Calcium Antagonists for Acute Ischemic Stroke
    J Zhang et al. Cochrane Database Syst Rev 2 (2), CD001928. PMID 30758052. - Meta-Analysis
    We found no evidence to support the use of calcium antagonists in people with acute ischemic stroke.
  • A Systematic Review of Vinpocetine Therapy in Acute Ischaemic Stroke
    D Bereczki et al. Eur J Clin Pharmacol 55 (5), 349-52. PMID 10456483. - Review
    Based on only one small randomised controlled unconfounded study, presently there is not enough evidence to decide whether the administration of vinpocetine does or does …
  • Interventions for Deliberately Altering Blood Pressure in Acute Stroke
    PM Bath et al. Cochrane Database Syst Rev (10), CD000039. PMID 25353321. - Review
    There is insufficient evidence that lowering blood pressure during the acute phase of stroke improves functional outcome. It is reasonable to withhold blood pressure-lowe …
  • Glycoprotein IIb-IIIa Inhibitors for Acute Ischaemic Stroke
    A Ciccone et al. Cochrane Database Syst Rev (3), CD005208. PMID 24609741. - Review
    The available trial evidence showed that, for individuals with acute ischaemic stroke, GP IIb-IIIa inhibitors are associated with a significant risk of intracranial haemo …
See all similar articles

Cited by 10 PubMed Central articles

See all "Cited by" articles

MeSH terms

LinkOut - more resources

Feedback